Annual Working Capital
$20.66 M
-$17.80 M-46.27%
31 December 2023
Summary:
Theriva Biologics annual working capital is currently $20.66 million, with the most recent change of -$17.80 million (-46.27%) on 31 December 2023. During the last 3 years, it has risen by +$15.70 million (+315.96%). TOVX annual working capital is now -68.36% below its all-time high of $65.30 million, reached on 31 December 2021.TOVX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$12.21 M
-$657.00 K-5.11%
01 September 2024
Summary:
Theriva Biologics quarterly working capital is currently $12.21 million, with the most recent change of -$657.00 thousand (-5.11%) on 01 September 2024. Over the past year, it has dropped by -$13.81 million (-53.08%). TOVX quarterly working capital is now -84.04% below its all-time high of $76.51 million, reached on 01 March 2021.TOVX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.3% | -53.1% |
| 3 y3 years | +316.0% | -81.3% |
| 5 y5 years | +85.3% | +9.5% |
TOVX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.4% | +316.0% | -81.3% | at low |
| 5 y | 5 years | -68.4% | +316.0% | -84.0% | +234.3% |
| alltime | all time | -68.4% | +593.5% | -84.0% | +188.6% |
Theriva Biologics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.21 M(-5.1%) |
| June 2024 | - | $12.87 M(-17.8%) |
| Mar 2024 | - | $15.65 M(-24.3%) |
| Dec 2023 | $20.66 M(-46.3%) | $20.66 M(-20.6%) |
| Sept 2023 | - | $26.02 M(-9.7%) |
| June 2023 | - | $28.83 M(-9.0%) |
| Mar 2023 | - | $31.68 M(-17.6%) |
| Dec 2022 | $38.46 M(-41.1%) | $38.46 M(-2.7%) |
| Sept 2022 | - | $39.54 M(-5.0%) |
| June 2022 | - | $41.62 M(-14.3%) |
| Mar 2022 | - | $48.58 M(-25.6%) |
| Dec 2021 | $65.30 M(+1214.5%) | - |
| Dec 2021 | - | $65.30 M(-7.2%) |
| Sept 2021 | - | $70.40 M(-4.3%) |
| June 2021 | - | $73.53 M(-3.9%) |
| Mar 2021 | - | $76.51 M(+1440.1%) |
| Dec 2020 | $4.97 M(-55.4%) | $4.97 M(+36.0%) |
| Sept 2020 | - | $3.65 M(-33.9%) |
| June 2020 | - | $5.53 M(-33.4%) |
| Mar 2020 | - | $8.29 M(-25.6%) |
| Dec 2019 | $11.15 M(-57.3%) | $11.15 M(-21.5%) |
| Sept 2019 | - | $14.21 M(-26.0%) |
| June 2019 | - | $19.20 M(-15.0%) |
| Mar 2019 | - | $22.59 M(-13.5%) |
| Dec 2018 | $26.13 M(+220.6%) | $26.13 M(+321.8%) |
| Sept 2018 | - | $6.19 M(+85.2%) |
| June 2018 | - | $3.35 M(-49.0%) |
| Mar 2018 | - | $6.56 M(-19.6%) |
| Dec 2017 | $8.15 M(+349.5%) | $8.15 M(+70.2%) |
| Sept 2017 | - | $4.79 M(+85.2%) |
| June 2017 | - | $2.59 M(+641.0%) |
| Mar 2017 | - | $349.00 K(-80.8%) |
| Dec 2016 | $1.81 M(-87.7%) | $1.81 M(-128.5%) |
| Sept 2016 | - | -$6.37 M(-1080.0%) |
| June 2016 | - | $650.00 K(-86.1%) |
| Mar 2016 | - | $4.69 M(-68.2%) |
| Dec 2015 | $14.76 M(+55.6%) | $14.76 M(-40.6%) |
| Sept 2015 | - | $24.84 M(-280.2%) |
| June 2015 | - | -$13.79 M(+702.4%) |
| Mar 2015 | - | -$1.72 M(-118.1%) |
| Dec 2014 | $9.48 M(-37.6%) | $9.48 M(+157.5%) |
| Sept 2014 | - | $3.68 M(-53.9%) |
| June 2014 | - | $8.00 M(-31.7%) |
| Mar 2014 | - | $11.71 M(-22.9%) |
| Dec 2013 | $15.19 M(+25.9%) | $15.19 M(+144.7%) |
| Sept 2013 | - | $6.21 M(-32.7%) |
| June 2013 | - | $9.23 M(-18.0%) |
| Mar 2013 | - | $11.26 M(-6.7%) |
| Dec 2012 | $12.07 M(+80.0%) | $12.07 M(+172.2%) |
| Sept 2012 | - | $4.43 M(-24.6%) |
| June 2012 | - | $5.88 M(-14.6%) |
| Mar 2012 | - | $6.88 M(+2.6%) |
| Dec 2011 | $6.71 M(+120.2%) | $6.71 M(-14.7%) |
| Sept 2011 | - | $7.86 M(-7.6%) |
| June 2011 | - | $8.51 M(+57.5%) |
| Mar 2011 | - | $5.40 M(+77.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $3.04 M(+30.7%) | $3.04 M(-9.6%) |
| Sept 2010 | - | $3.37 M(+16.9%) |
| June 2010 | - | $2.88 M(+68.3%) |
| Mar 2010 | - | $1.71 M(-26.4%) |
| Dec 2009 | $2.33 M(-56.1%) | $2.33 M(-31.2%) |
| Sept 2009 | - | $3.38 M(-16.7%) |
| June 2009 | - | $4.06 M(-13.7%) |
| Mar 2009 | - | $4.71 M(-11.2%) |
| Dec 2008 | $5.31 M(-46.2%) | $5.31 M(-8.8%) |
| Sept 2008 | - | $5.82 M(-13.2%) |
| June 2008 | - | $6.70 M(-10.9%) |
| Mar 2008 | - | $7.53 M(-23.7%) |
| Dec 2007 | $9.87 M(-14.1%) | $9.87 M(+58.9%) |
| Sept 2007 | - | $6.21 M(-20.9%) |
| June 2007 | - | $7.85 M(-23.3%) |
| Mar 2007 | - | $10.23 M(-11.0%) |
| Dec 2006 | $11.49 M(-1265.2%) | $11.49 M(<-9900.0%) |
| Sept 2006 | - | -$3000.00(<-9900.0%) |
| June 2006 | - | $0.00(-100.0%) |
| Mar 2006 | - | -$9400.00(-99.8%) |
| Dec 2005 | -$986.00 K(-76.5%) | - |
| Mar 2003 | - | -$4.86 M(+16.0%) |
| Dec 2002 | -$4.19 M(+0.6%) | -$4.19 M(+73.1%) |
| Sept 2002 | - | -$2.42 M(+84.4%) |
| June 2002 | - | -$1.31 M(+60.9%) |
| Mar 2002 | - | -$815.40 K(-80.4%) |
| Dec 2001 | -$4.16 M(-221.0%) | -$4.16 M(+655.3%) |
| Sept 2001 | - | -$550.90 K(-153.6%) |
| June 2001 | - | $1.03 M(-48.8%) |
| Mar 2001 | - | $2.01 M(-41.7%) |
| Dec 2000 | $3.44 M(+2.8%) | $3.44 M(+63.0%) |
| Sept 2000 | - | $2.11 M(-19.0%) |
| June 2000 | - | $2.61 M(-47.1%) |
| Mar 2000 | - | $4.92 M(+47.2%) |
| Dec 1999 | $3.34 M(+138.9%) | $3.34 M(-1214.7%) |
| Sept 1999 | - | -$300.00 K(-150.0%) |
| June 1999 | - | $600.00 K(-40.0%) |
| Mar 1999 | - | $1.00 M(-28.6%) |
| Dec 1998 | $1.40 M(-255.6%) | $1.40 M(-26.3%) |
| Sept 1998 | - | $1.90 M(-59.6%) |
| June 1998 | - | $4.70 M(-256.7%) |
| Mar 1998 | - | -$3.00 M(+233.3%) |
| Dec 1997 | -$900.00 K(-164.3%) | -$900.00 K(<-9900.0%) |
| Sept 1997 | - | $0.00(-100.0%) |
| June 1997 | - | -$100.00 K(-105.6%) |
| Mar 1997 | - | $1.80 M(+28.6%) |
| Dec 1996 | $1.40 M(-12.5%) | $1.40 M(-61.1%) |
| Sept 1996 | - | $3.60 M(-18.2%) |
| June 1996 | - | $4.40 M(+158.8%) |
| Mar 1996 | - | $1.70 M(+6.3%) |
| Dec 1995 | $1.60 M(-300.0%) | $1.60 M(-42.9%) |
| Sept 1995 | - | $2.80 M(-450.0%) |
| Dec 1994 | -$800.00 K(-153.3%) | -$800.00 K(-118.2%) |
| Mar 1994 | - | $4.40 M(+193.3%) |
| Dec 1993 | $1.50 M | $1.50 M(-64.3%) |
| June 1993 | - | $4.20 M(+2.4%) |
| Mar 1993 | - | $4.10 M |
FAQ
- What is Theriva Biologics annual working capital?
- What is the all time high annual working capital for Theriva Biologics?
- What is Theriva Biologics annual working capital year-on-year change?
- What is Theriva Biologics quarterly working capital?
- What is the all time high quarterly working capital for Theriva Biologics?
- What is Theriva Biologics quarterly working capital year-on-year change?
What is Theriva Biologics annual working capital?
The current annual working capital of TOVX is $20.66 M
What is the all time high annual working capital for Theriva Biologics?
Theriva Biologics all-time high annual working capital is $65.30 M
What is Theriva Biologics annual working capital year-on-year change?
Over the past year, TOVX annual working capital has changed by -$17.80 M (-46.27%)
What is Theriva Biologics quarterly working capital?
The current quarterly working capital of TOVX is $12.21 M
What is the all time high quarterly working capital for Theriva Biologics?
Theriva Biologics all-time high quarterly working capital is $76.51 M
What is Theriva Biologics quarterly working capital year-on-year change?
Over the past year, TOVX quarterly working capital has changed by -$13.81 M (-53.08%)